| |
Tuesday, December 6, 2022 | 12pm ET/9am PT Biopharma customers are now demanding that the vendor industry work collaboratively to connect their scientific workflows. This webinar will provide valuable insights for biopharmaceutical scientists, lab directors, IT professionals, and life science vendors. Register now. 
|
|
Today's Big NewsNov 21, 2022 |
|
Tuesday, December 6, 2022 | 10am ET / 7am PT The development of therapeutic antibodies has been challenged by the difficulty to generate such intricate molecules. Here, we show that ProBio has established proprietary fast CMC platform guaranteeing the delivery of monoclonal antibody with high titer. Register now. 
|
|
| By Max Bayer Amid a tumultuous biotech market, clinical dead ends can be even more financially perilous. This year's Biotech Graveyard takes a look back at some of the companies that were forced to close up shop. |
|
|
|
By Kevin Dunleavy For nearly five decades, women in the U.S. had the constitutional right to abortion, until it was revoked earlier this year by the Supreme Court. Now, emboldened by the ruling, anti-abortion medical organizations are taking aim at pills that induce miscarriage and have been on the market in the U.S. for more than two decades. Friday, the conservative Alliance Defending Freedom filed suit in Amarillo, Texas, against the FDA, challenging the agency’s 2000 approval of Mifeprex. |
By Paige Minemyer The feds want another shot at blocking UnitedHealth Group's acquisition of Change Healthcare. |
By Andrea Park Philips has paused the repair efforts for affected Trilogy 100 and 200 series ventilators after receiving “a limited number of complaints” related to remediated machines, which are now under investigation. |
|
Tuesday, December 7th, 2022 | 10am ET/7am PT In this presentation we’ll review how we established GOCHO™ cells from an adherent CHO-K1 cell line to meet current industry standards, how the choice of cloning media drove cell culture media choices for the entire cell-line development process, and more. Register now. 
|
|
By Nick Paul Taylor Merck has opened its wallet wide to buy a midphase treatment for life-threatening diseases of the bone marrow, paying $1.35 billion to snap up Imago BioSciences for its oral LSD1 inhibitor bomedemstat. |
By Heather Landi About 22,000 nurses and nurse practitioners reached a tentative agreement with Kaiser Permanente on a new four-year contract that includes provisions for a 22.5% raise and increased staffing. |
By Angus Liu Pfizer’s oral COVID drug Paxlovid has become a standard of care for treating non-severe patients in high-income countries. But advocacy groups remain critical of the drug’s lack of equal access, just as the WTO is scheduled to make a decision on forced patent waiver for treatments and tests. |
By Andrea Park An Apple Watch app from H2o Therapeutics certainly seems to hold water as a Parkinson’s disease monitoring system, as the FDA handed down 510(k) clearance for the technology last week. |
By Max Bayer Merck KGaA is turning to business development to bolster its pipeline amid a company-wide effort to massively expedite clinical development. But efforts to become a "leaner" organization may mean layoffs are on the horizon. |
By Robert King Sens. Bernie Sanders, I-Vermont, and Bill Cassidy, R-Louisiana, are expected to lead the Senate HELP Committee, which has sway over key health policy areas. |
By Nick Paul Taylor AbbVie and Genmab have glided into Roche’s slipstream in the race to bring a CD3xCD20 bispecific to market, securing FDA priority review and a May decision date—and triggering an $80 million milestone payment in the process. |
By Conor Hale The two companies will be able to combine their respective methods for taking MRIs, known as sequences, into a single automated clinical imaging protocol. |
By Fraiser Kansteiner On Monday, WuXi Biologics cut the ribbon on its integrated biologics contract research, development and manufacturing center in the Fengxian district of Shanghai. The ascendant contractor’s latest China facility makes nine in its home country. |
Fierce podcasts Don't miss an episode |
| This week on “The Top Line,” we share this week's headlines and discuss the 2022 honorees in our annual Fiercest Women in Life Sciences report. |
|
|---|
|
|
|
Tuesday, December 6, 2022 | 2pm ET / 11am PT In this webinar, we will cover how interoperability between EMS and the hospital can help elevate patient care while maximizing hospital revenue and how you can leverage your relationships with EMS to help manage and treat your most critical patients. Register Now. 
|
|
Whitepaper Learn how to develop a high-performing supply chain for GMP-manufactured chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific. Sponsored by: Thermo Fisher Scientific |
Whitepaper Preparation of critical process liquids and buffer components shifts resources away from core activities and can be filled with inefficiencies and risks that can increase time and costs across your workflow. Learn about the framework to help reduce your total costs beyond capital and operational expenditures and set a solid foundation for successful scale-up of buffer preparation. Sponsored by: Thermo Scientific Production Chemicals and Services |
Webinar Twist Bioscience CSO Dr. Aaron Sato shares how Twist's tools for antibody discovery have been applied to identify antibodies against diverse and challenging targets. See how high-throughput DNA synthesis combined with antibody engineering expertise provides end-to-end antibody discovery solutions. Presented by: Twist Bioscience |
Whitepaper This paper outlines how gene therapy supply chains are different from traditional biopharma products, as well as the factors that are essential to success. Sponsored by: Blue Matter |
Video Revolutionize your monoclonal antibody (mAb) manufacturing process with the Gibco™️ Efficient-Pro™️ Medium and Feed System. Watch our how-to video. Sponsored by: Thermo Fisher Scientific |
| |
|
